Active Motif
1914 Palomar Oaks Way
Suite 150
Carlsbad
California
92008
United States
Tel: 877-222-9543 or 760-431-1263
Fax: 760-431-1351
Website: http://www.activemotif.com/
15 articles about Active Motif
-
Active Motif Partners with Arima Genomics to Launch End-to-End Hi-C Service
2/9/2021
Epigenetics-based research tools and services company, Active Motif, Inc., announced that it has launched an end-to-end Hi-C service in partnership with Arima Genomics, Inc. to investigate the three-dimensional folding patterns of the genome, providing researchers with greater access to this powerful technology and advancing their research.
-
Active Motif Announces New Report Describing Advancements in Generation and Characterization of Their Recombinant Human COVID-19 Antibodies with Qualities that Make Them Ideal for Use in Diagnostics and Therapeutics
6/16/2020
Active Motif, a company with the vision of bringing the field of epigenetics into personalized medicine, announces access to a pre-print publication associated with their COVID-19 efforts in China to isolate, develop, and deliver high-value fully human recombinant SARS-CoV-2 antibodies to the market.
-
Active Motif launches a portfolio of recombinant COVID-19 antibodies; the first full human antibodies derived from patients infected with the 2019 Coronavirus, now available for research and commercial use
4/10/2020
Active Motif announced the successful isolation of antibodies from patients in China recovering from 2019 Coronavirus related pneumonia.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 10, 2020.
-
Active Motif clones, sequences and expresses the first full human antibody derived from patients infected with the 2019 Coronavirus COVID-19
2/26/2020
Active Motif Shanghai, in collaboration with Fudan University and its affiliated Public Health Clinical Center, used its single-cell AbEpicâ„¢ screening technology to isolate antibodies from patients recovering from 2019 Coronavirus related pneumonia.
-
Forge Therapeutics And Active Motif To Collaborate On Epigenetic Research And Drug Discovery
3/28/2016
-
Active Motif And Ghent University Announce The Deployment Of TimeLogic Corporation's Hardware-Accelerated Genome Analysis System In The Department Of Plant Biotechnology And Bioinformatics
2/26/2014
-
Active Motif Announces That The Center for Biotechnology (Cebitec) At Bielefeld University Has Deployed Timelogic's J-Series FPGA-Based Hardware Accelerated Biocomputing Platform
1/28/2014
-
Active Motif Acquires SwitchGear Genomics Further Expanding Gene Regulation Product Offerings
3/22/2013
-
Active Motif and the Center for Biotechnology (Cebitec) Form Partnership to Jointly Develop Computational Tools for TimeLogic Corporation's FPGA-Based Hardware Accelerated Bioinformatics Platform
11/14/2011
-
Active Motif Acquires Genpathway, Inc. Further Expanding Epigenetics Product Offering
12/2/2010
-
Active Motif Awarded SBIR Grant to Develop Chromatin IP of Clinical Samples
11/17/2010
-
Invitrogen Corporation and Active Motif Explore Use of FPGA Technology for Next-Generation Sequencing Data Analysis
7/21/2008
-
National Institutes of Health (NIH) Signs a Multi-Year Deal With Active Motif for AKS2 Software
5/20/2008
-
Translational Genomics Research Institute (TGen) Licenses AKS2 From Active Motif
2/9/2007